Cognitive-behavioral Therapy for Insomnia in Adolescent Psychiatry
2012/871-31/1
1 other identifier
interventional
25
0 countries
N/A
Brief Summary
The study is a clinical pilot study that examine the preliminary effect of cognitive-behavioral therapy for insomnia (CBT-I) in adolescents with comorbid psychiatric disorders. Participants (n=25) are recruited from three psychiatric clinics (n=19) and one pediatric pain clinic (n=6). After diagnostic assessment, participants that fulfil inclusion criteria are offered the CBT-I intervention. Pre-post and 3-months follow-up assessments include subjective measures of insomnia symptom severity, sleep parameters (collected through sleep-wake diaries), symptoms of depression and anxiety and daytime functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2018
CompletedFirst Submitted
Initial submission to the registry
September 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 23, 2019
CompletedOctober 23, 2019
October 1, 2019
2.8 years
September 3, 2019
October 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline Insomnia Severity Index- adolescent version (ISI-a)
The Insomnia Severity Index, ISI -adolescent version18 was used before, after at three months follow-up to measure insomnia symptom severity. ISI-a is an adaptation to adolescents of the Insomnia Severity Index32,36. ISI-a is a seven-item measure that yields a quantitative index of sleep impairment and treatment outcome. Total scores range from 0 to 28, with higher scores indicating greater perceived insomnia severity.
6 weeks and 3 months
Secondary Outcomes (6)
Sleep Onset Latency (SOL)
Baseline, 6 weeks and 3 months
Wake after sleep onset (WASO)
Baseline, 6 weeks and 3 months
Total Sleep Time (TST)
Baseline, 6 weeks and 3 months
Sleep Efficiency (SE)
Baseline, 6 weeks and 3 months
Spences' Children Anxiety Scale (SCAS)
Baseline, 6 weeks and 3 months
- +1 more secondary outcomes
Study Arms (1)
CBT-I
EXPERIMENTALInterventions
The theoretical framework is cognitive-behavioral therapy that includes sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive interventions and relaxation. The intervention has been adapted to adolescents by reducing the amount of psychoeducational information and the interventions related to changing cognitions. It involves six weekly face-to-face individual sessions with a therapist, supported by a participant workbook that contains information, work- sheets, and at-home tasks. Clinical psychologists or graduate clinical psychologists in training delivered the intervention sessions under supervision by the first author. Parents/care-givers were given information about the components, but did not take active part of the intervention.
Eligibility Criteria
You may qualify if:
- be between 13-17 years old
- meet criteria for insomnia disorder (primary or secondary insomnia) according to DSM-IV-TR
- have insomnia symptoms at a clinical level, as defined as more than 10 points on the ISI-a
- adequate Swedish language skills
You may not qualify if:
- severe psychiatric disorder that is contraindicative of the treatment (i.e., bipolar disorder, psychotic disorder)
- autistic disorder
- severe suicidality (defined as ≥17 points on MINI-kid suicide subscale)
- alcohol or drug dependence
- psychotropic medication
- previous (\> 5 sessions) or ongoing CBT-treatment for insomnia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Stockholm Universitycollaborator
- Child and Adolescent Psychiatry, Stockholmcollaborator
- Karolinska University Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mats Lekander, Professor
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 3, 2019
First Posted
October 23, 2019
Study Start
April 1, 2015
Primary Completion
December 31, 2017
Study Completion
January 30, 2018
Last Updated
October 23, 2019
Record last verified: 2019-10